India MRI: Indigenous Tech & Healthcare Impact

India’s MRI market, currently valued at USD 260–280 million, is poised for substantial growth, potentially exceeding USD 400 million by the end of the decade. This expansion is fueled by a rising prevalence of non-communicable diseases, advancements in cancer diagnostics, and the broadening of hospital infrastructure beyond major metropolitan areas. However, over 90% of MRI machines in India are imported, making this crucial diagnostic tool exceptionally expensive and operationally complex.

A Homegrown MRI: India’s Bid for Healthcare Independence

A Bengaluru startup is challenging the status quo with a potentially transformative, helium-free MRI scanner.

• India heavily relies on imported MRI machines, creating cost and logistical challenges.
• VoxelGrids, backed by Zoho, has developed a domestically produced, helium-free 1.5 Tesla MRI scanner.
• This innovation could significantly reduce costs and improve access to MRI technology, particularly in Tier-2 and Tier-3 cities.
• The success of this venture hinges on building trust in the quality and reliability of the new technology.

VoxelGrids, a Bengaluru-based startup supported by Zoho, is attempting to reshape India’s medical device landscape with the announcement of a homegrown, helium-free MRI scanner. This development, guided by the Government of India’s new Software as a Medical Device (SaMD) guidelines, isn’t simply a technological feat—it’s a story about affordability, accessibility, national sovereignty, and building a more resilient healthcare system.

Why MRI Has Always Been a Challenge for India

MRI technology occupies a unique position within Indian healthcare. While clinically essential for neurology, oncology, musculoskeletal disorders, cardiac imaging, and increasingly, whole-body screening, the economic realities have often placed it out of reach for many hospitals. A standard imported 1.5– or 3-T MRI machine can cost between ₹8–15 crore, excluding the substantial expenses of civil works, shielding, service contracts, and ongoing helium refills. This financial burden often renders MRI unfeasible or necessitates heavy reliance on debt and leasing arrangements for hospitals in Tier-2 and Tier-3 cities.

This dependence on imports also introduces systemic vulnerabilities. Supply chain disruptions, fluctuations in foreign exchange rates, the availability of service engineers, and logistical challenges related to spare parts all contribute to operational friction. Over time, MRI has become emblematic of a broader issue within the Indian medtech sector: clinical sophistication coupled with a lack of manufacturing control.

The VoxelGrids Breakthrough: More Than Just “Made in India”

VoxelGrids’ endeavor is significant because it challenges three long-held assumptions. First, that the design and manufacturing of MRI machines must remain the exclusive domain of global industry giants. Second, that reliance on helium is unavoidable. And third, that cost reductions in MRI technology can only be achieved through refurbished or downgraded systems.

The company’s indigenous 1.5 Tesla MRI scanner, developed with support from India’s biotechnology ecosystem, is reportedly 40% cheaper to manufacture than imported alternatives. This cost advantage isn’t merely cosmetic; it fundamentally alters the procurement calculations for hospitals, particularly those outside major metropolitan areas. Equally important, it signals India’s potential to transition from “assembly” to “deep-tech system engineering” in the medical device industry.

The Helium Problem—And Why Solving It Matters

To grasp the significance of this advancement, it’s crucial to understand the role of helium. Traditional MRI machines utilize liquid helium to cool superconducting magnets to near absolute zero. Helium is a scarce, expensive, and globally constrained resource. Any disruption to the supply—whether geopolitical or logistical—directly impacts MRI uptime. For Indian hospitals, especially those outside of major cities, helium refills are not only costly but also present significant operational hurdles.

VoxelGrids’ MRI is designed to be helium-free or near-zero helium, employing alternative magnet and cooling architectures. This simultaneously reduces lifetime operating costs and dramatically simplifies maintenance procedures. For hospital administrators, this isn’t just an engineering curiosity—it directly affects uptime, cash flow, and patient throughput. In many ways, helium-free MRI represents a structural unlock for imaging, akin to the impact of solar power on rural electrification.

India’s Medical Devices Story: A Broader Perspective

This development arrives at a pivotal moment in India’s medical device trajectory. The Indian medical devices market is estimated at USD 11–13 billion and is growing at a compound annual growth rate (CAGR) of 10–12%. Imaging devices represent one of the highest-value segments within this market, yet also one of the most import-dependent. Government initiatives, such as Production Linked Incentive (PLI) schemes, targeted research and development funding, and hospital procurement reforms, are all encouraging local innovation—though progress has been uneven.

Indigenous MRI technology changes the narrative by existing at the intersection of capital equipment, advanced physics, software, and clinical trust. If India can successfully manufacture MRI machines, it can confidently aspire to develop CT scanners, linear accelerators, and other complex imaging and therapy platforms.

How Big Is the MRI Opportunity?

Currently, India has an estimated 2,500–3,000 MRI scanners installed, with a disproportionate concentration in metropolitan areas and large private hospital chains. The scanner-to-population ratio remains significantly below OECD averages. As insurance coverage expands and clinical protocols increasingly mandate MRI for early diagnosis, demand will not only grow but also become more geographically dispersed.

Conservative projections suggest 200–300 new MRI installations per year over the next decade. If indigenous players can capture even 15–20% of this incremental demand, it represents a substantial domestic market opportunity, not to mention potential exports to other price-sensitive emerging markets in Asia, Africa, and Latin America.

Technology or Trust: What Will Determine Success?

It’s important to acknowledge a critical point: MRI adoption isn’t solely driven by price. Radiologists prioritize image quality, consistency, software upgrades, and responsive service. Hospitals focus on uptime, financing models, and resale value. Global original equipment manufacturers (OEMs) have spent decades cultivating trust in these areas.

For VoxelGrids—and any future Indian MRI manufacturer—the true challenge lies not in building the machine itself, but in building confidence. Clinical validation, regulatory approvals, long-term service guarantees, and seamless integration with radiology workflows will determine whether this remains a symbolic victory or evolves into a scaled industry.

A Different Moment for “Make in India”

Despite these challenges, this moment feels distinct from previous “Make in India” initiatives. The emphasis isn’t on low-end substitution, but on fundamentally re-architecting the product—eliminating helium, lowering lifetime costs, and aligning the machine with Indian operating realities. This design philosophy, if sustained, can become India’s competitive advantage rather than a weakness.

More importantly, it reflects a maturing ecosystem where private capital, government funding, and clinical expertise are beginning to converge. This alignment has historically been lacking in the Indian medtech sector.

What is the biggest challenge facing the adoption of domestically produced MRI scanners in India? Building trust in the quality, reliability, and long-term support of these new machines is paramount, as radiologists and hospitals prioritize image quality, uptime, and service.

India’s indigenous MRI effort may not generate headlines like a new drug discovery, but its long-term impact could be equally profound. In a market valued at hundreds of millions of dollars annually, with significant clinical relevance and strategic importance, local MRI manufacturing represents a shift from dependence to capability.

If successful, this will not only reduce MRI costs—it will change who has access to advanced diagnostics, how hospitals plan capital expenditures, and how India positions itself within the global medtech value chain. The real story, therefore, isn’t about a single machine, but about whether India is finally prepared to tackle the most complex challenges in healthcare technology.